Quinidine Sulfate for Horses: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Quinidine sulfate is a prescription antiarrhythmic medication used in horses, most often to convert atrial fibrillation (AF) back to a normal sinus rhythm. In equine medicine, it has long been one of the main medical options for AF, especially in horses without severe structural heart disease or heart failure.

It is usually given orally by nasogastric tube under close veterinary supervision rather than as a routine at-home medication. Quinidine has a narrow safety margin, which means the difference between an effective dose and a toxic dose can be small. Because of that, treatment is typically done in a hospital or referral setting with ECG monitoring and repeated physical exams.

This drug affects how electrical impulses move through the heart. That can help stop atrial fibrillation, but it can also trigger dangerous rhythm changes in some horses. Your vet may recommend quinidine sulfate, another quinidine formulation, or a non-drug option such as transvenous electrical cardioversion depending on your horse's exam findings, duration of AF, athletic demands, and monitoring resources.

In horses, quinidine sulfate is used primarily for atrial fibrillation, the most common clinically important arrhythmia in adult horses. Some horses with AF show poor performance, exercise intolerance, or an irregular heartbeat found on exam. Others may seem normal at rest and only struggle during work.

The goal of treatment is to restore a normal rhythm when that is appropriate for the individual horse. Quinidine tends to work best in carefully selected cases, especially when AF is of shorter duration and the horse does not have major underlying heart disease. Reported success rates in the literature are often high, but they are not 100%, and recurrence can happen.

Your vet may discuss quinidine sulfate when a horse is a performance athlete, has reduced exercise capacity, or has a ventricular response pattern that makes AF less safe. In horses that do not respond well to quinidine, cannot tolerate it, or have had AF for a long time, referral options such as transvenous electrical cardioversion (TVEC) may be considered.

Quinidine sulfate dosing in horses must be individualized by your vet. A commonly cited regimen is 22 mg/kg by mouth every 2 hours, usually administered by nasogastric tube, with treatment stopped once the horse converts to sinus rhythm, develops adverse effects, or reaches the planned maximum number of doses. Merck also notes that a 10 mg/kg oral test dose can be considered because idiosyncratic reactions have been reported.

In practice, many equine cardiology protocols use an initial series of doses every 2 hours, then may extend the interval if the horse has not converted but is tolerating treatment. Exact total dose limits, whether to continue beyond the first few doses, and whether to add other medications depend on ECG findings, heart rate response, blood pressure, and the horse's overall condition.

This is not a medication pet parents should try to dose on their own. Horses receiving quinidine usually need continuous or frequent ECG monitoring, repeated heart rate checks, and observation for widening of the QRS complex, rising ventricular rate, hypotension, diarrhea, colic signs, nasal swelling, or neurologic changes. If your horse has heart failure, low blood pressure, or significant structural heart disease, your vet may recommend a different plan.

Quinidine sulfate can cause both common side effects and serious toxic effects in horses. Reported adverse effects include nasal mucosal swelling, urticarial wheals, gastrointestinal upset, hypotension, and laminitis. Because it changes cardiac conduction, the most important risk is worsening arrhythmia, including potentially dangerous ventricular arrhythmias.

Pet parents may notice restlessness, depression, weakness, diarrhea, colic-like discomfort, facial or nasal swelling, or a horse that suddenly seems less stable or more distressed during treatment. Some horses develop a faster ventricular response because quinidine has atropine-like effects on AV nodal conduction. That is one reason close ECG monitoring matters so much.

See your vet immediately if a horse on quinidine develops collapse, marked weakness, severe diarrhea, worsening irregular rhythm, very fast heart rate, breathing difficulty, or signs of foot pain that could suggest laminitis. Even mild changes deserve prompt attention, because quinidine toxicity can escalate quickly.

Quinidine sulfate has several clinically important drug interactions. In horses with atrial fibrillation, digoxin may sometimes be added if conversion has not occurred after 24 to 48 hours, but quinidine can increase plasma digoxin concentrations. If these drugs are used together, your vet will usually monitor closely and may adjust the plan based on response and drug levels.

Because quinidine affects cardiac conduction and blood pressure, caution is also needed with other drugs that can alter rhythm, slow conduction, or change electrolyte balance. Interactions may be more likely to matter in horses receiving other antiarrhythmics, sedatives, or medications that affect potassium status, blood pressure, or gastrointestinal motility.

Human drug references and equine pharmacology sources also note that drugs such as cimetidine may increase quinidine exposure. The safest approach is to give your vet a full medication and supplement list, including electrolytes, ulcer medications, and any recent cardiac drugs, before treatment starts.